MedPath

Strength Training for Older Breast Cancer Survivors

Not Applicable
Completed
Conditions
Breast Neoplasm
Osteoporosis, Postmenopausal
Interventions
Behavioral: Resistance Exercise
Behavioral: Flexibility Training
Registration Number
NCT00591747
Lead Sponsor
OHSU Knight Cancer Institute
Brief Summary

Women aged 50 and older are disproportionately affected by breast cancer, not only in terms of new diagnoses, but also in terms of survivorship. Approximately 85% of women who receive a first diagnosis of breast cancer are aged 50 and over, thus older women constitute the largest group of breast cancer survivors. Yet, few studies have focused on evaluating whether physical activity and exercise interventions affect long-term symptoms, physical fitness and function, and body composition of older breast cancer survivors. Due to the combined effects of breast cancer, related treatments and aging it is likely that exercise is even more beneficial for older breast cancer survivors than for younger survivors. Along with the cancer-related symptom of fatigue common to cancer survivors, older survivors face age-related declines in bone and muscle mass, muscle strength, bone health and physical function (gait and balance) that are likely exacerbated by reduced physical activity in survivorship and side effects of adjuvant cancer treatment. All women, regardless of age, are at risk for breast cancer recurrence. Recent epidemiologic evidence suggests a link between exercise and reduced risk of cancer recurrence in breast cancer survivors. Strength training is specifically suited to reverse or slow age-related declines in bone, muscle, strength and function and has shown promise to reduce cancer-related fatigue. However, no controlled trials of strength training in older breast cancer survivors have been conducted.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
106
Inclusion Criteria
  • Diagnosed with early stage breast cancer at age of 50 or older
  • Completed adjuvant therapy, radiation +/- chemotherapy but selective estrogen receptor modulators (SERMS), (aromatase inhibitors (AIs) ok) at least 1 year prior to enrollment
Exclusion Criteria
  • Cognitive difficulties that preclude answering the survey questions, participating in performance testing or giving informed consent
  • Diagnosed osteoporosis
  • Current regular participation in planned impact activities or resistance training (more than 2 times a week for 30 minutes at a time)
  • Medication that contraindicates participation in moderate intensity strength training or previous use of medications known to affect bone metabolism
  • Movement or neurologic disorder, not including chemo-induced peripheral neuropathy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
1Resistance ExerciseProgressive resistance training program 3 times a week for 12 months
2Flexibility TrainingFlexibility training 3 times a week for 12 months
Primary Outcome Measures
NameTimeMethod
Physical functioning (muscle strength, gait and balance), self-report physical and mental health, and fatigue12 months
Secondary Outcome Measures
NameTimeMethod
Body composition (fat mass, muscle mass) and bone mineral density of the lumbar spine and proximal femur12 months

Trial Locations

Locations (1)

OHSU School of Nursing

🇺🇸

Portland, Oregon, United States

© Copyright 2025. All Rights Reserved by MedPath